WHO Approves New Dengue Vaccine

WHO Approves New Dengue Vaccine

The World Health Organization (WHO) has approved a new dengue vaccine called TAK-003. It was developed by a Japanese pharmaceutical named Takeda. This is the second dengue vaccine to receive WHO validification. Previously, another vaccine by the name of CYD-TDV was approved by WHO in 2015.

Dengue is a serious disease spread by mosquitoes. It affects between 100 and 400 million people each year. Most cases are in Asia, Africa, and the Americas. This approval will help the vaccine be used all around the world, especially in poorer countries. 

TAK-003 vaccine contains weakened forms of the four types of dengue virus. This will help the body build immunity without causing the disease. The vaccine is recommended for children aged 6 to 16 in areas with high rates of dengue. It is given in two doses, three months apart.

The verification by WHO of TAK-003 means major global health groups can buy it. Countries such as the UK, Brazil, Argentina, Indonesia, and Thailand have also approved the use of this vaccine.